BLPH

INOpulse® | COViNOX

COVID-19

Phase 2/3 (Publication of Data in Chest Journal)

Exp Date

August 2020 (Est)

Amp Volatility Score

Catalyst Info & Data Links

TITLE: INOpulse® for COVID-19 - Phase 2/3 Publication of Data in CHEST Journal


ClinicalTrial.gov 

  • Phase 2 (NCT04388683): Inhaled Nitric Oxide for Preventing Progression in COVID-19 (NO-COVID-19)

  • Phase 2 (NCT04398290): iNOPulse for COVID-19 (NO-COVER)

  • Phase 3 (NCT04421508): A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 (COViNOX)


WHAT IS THE NEXT CATALYST EVENT?

  • Publication of "positive" Phase 2b "Cohort 1 data in the journal "Chest"


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?


PRIOR DATA

PRESS RELEASES

PRESENTATIONS

MECHANISM OF ACTION / RATIONALE

  • The INOpulse platform is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. Use of inhaled nitric oxide is approved by the U.S. Food and Drug Administration (FDA) and other regulatory authorities across the world to treat persistent pulmonary hypertension of the newborn. The INOpulse technology utilizes targeted pulsatile delivery of inhaled nitric oxide, allowing it to be extended into chronic use applications (learn more). 

Updated by HC

#BLPH, #INOpulse, #COVID-19, #coronavirus

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

BLPH - Phase 2/3 Publication o...

It will be interesting to see more details of BLPH COViNOX (inhaled nitric oxide) Phase 2 COVID data published in the journal CHEST, we believe tomorrow August 1, 2020. See more details about COViNO...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon